Synopsis
Further understanding of the association of hemoglobin
A1c(HbA1c) levels with symptomatic carotid plaque characteristics will
be helpful for stroke risk stratification and treatment strategy modification. This
study sought to investigate the associations of HbA1c levels with MR-identified
carotid plaque characteristics in hypertensive patients with acute stroke. Our
key findings are that elevated HbA1c was associated with carotid plaque
presence, higher HbA1c level tended to exhibit an increased plaque
burden and larger lipid-rich necrotic core, independent of other cardiovascular
risk factors. Our findings indicate that elevated HbA1c may
contribute to the development of advanced carotid plaques in stroke patients
with hypertension.Introduction
Diabetes and
hypertension have important effects on the
burden of stroke and increased risk of
atherosclerosis. Previous studies have shown that
high levels of hemoglobin A
1c (HbA
1c) is associated with
an increased risk of atherosclerosis assessed as carotid intima-media thickness
or plaque prevalence by ultrasound
1,2. However, few studies have reported an
association between HbA
1c levels and MR-identified carotid plaque characteristics in hypertensive patients
with acute stroke.
Purpose
To determine the associations of HbA
1c
level with the carotid atherosclerotic lesions with emphasis on
plaque morphological and compositional characteristics by MR vessel wall
imaging in hypertensive patients with acute stroke.
Methods
Study
population
Eighty-four
hypertensive patients with acute ischemic stroke in the anterior circulation
were recruited. All subjects underwent HbA1c measurements and
carotid artery black-blood MR imaging within 1 week after onset of
symptoms. Extensive clinical workup (lab, brain MRA, duplex sonography and
24-hour ECG ) was performed to exclude other causes of ischemic stroke.
Carotid MR imaging and image interpretation
A multi-contrast black-blood
imaging protocol(T1WI,T2WI,MP-RAGE and time of flight) described before3 was
performed on a whole body 3.0T MR scanner (Philips Achieva, Best, the
Netherlands) with an 8 channel phased-array carotid coil to acquire the
cross-sectional carotid MR images. Carotid MR images were analyzed using a
custom program (CASCADE, Seattle, WA, USA)4. The values of luminal stenosis,
maximum wall thickness (Max WT), the percent wall volume (PWV=100% × wall
volume/total vessel volume) and the proportion of each component relative to
the wall volume including calcification (CA), lipid-rich necrotic core (LRNC)
and intraplaque hemorrhage (IPH) (eg, % volume of LRNC = 100% ×LRNC volume/wall
volume) along the symptomatic side were measured based on previously published
criteria validated by histology5.
Data analysis
We
divided the patients into two groups by the HbA1c status in Asian
adults6 (group
1: ≤6.0%; group 2: >6.0 %). These two groups’ clinical
profiles and symptomatic carotid plaque features were compared. Logistic
regression was performed to assess the association between HbA1c and
the presence of symptomatic carotid plaques as well as the LRNC size after adjustment for other cardiovascular risk factors and
demographic factors. ROC curve was generated from multiple
sensitivity/specificity pairs to evaluate the diagnostic efficiency and identify the optimal
cutoff level of HbA1c for diagnosing carotid lesions.
Results
Four patients were excluded because of inadequate MR image quality. Of the remaining
80 subjects, 62 (77.5%) were male, 37 (46.3%) had history of type 2 diabetes mellitus, and
the mean age was 63.6 ± 10.8 years. Compared with HbA
1c ≤6%,
larger plaque burden and higher prevalence of a large LRNC
were found in HbA
1c >6 % (Table 1). Of note, the multivariate logistic
regression analysis in Figure 1 showed that HbA
1c > 6% (OR,4.75;
95% CI:1.44 to 15.60,
P <0.05)
and current smoking (OR,4.37; 95% CI:1.26 to 15.17,
P <0.05) were independently risk factors for the presence of LRNC
plaques. Moreover, an increasing trend was observed in HbA
1c level
in carotid arteries without plaque, with plaque and ≤40%
LRNC, and with plaque and >40% LRNC (
P
<0.001, Figure 2,3). The ROC curve showed that the optimal threshold of HbA
1c
level to predict the presence of symptomatic plaque and %volume of LRNC>40%
was 6.36% and 7.22%, respectively (Figure 4).
Discussion and Conclusions
Our findings demonstrate that elevated HbA
1c
was associated with plaque presence, higher HbA
1c level tended
to exhibit an increased plaque burden
and larger LRNC size, independent of other cardiovascular risk factors in those
symptomatic patients with hypertension. Our results are in accordance with the
results from most of these ultrasonography studies
1,2,7 and extend them
with regard to the relationship with plaque compositional characteristics, suggesting
that HbA
1c are useful for assessing carotid atherosclerosis and
plaque vulnerability. Because of the cross-sectional study design, we cannot formally
conclude that a high HbA1c level is causally related to advanced atherosclerosis.
Prospective follow-up studies should be conducted to determine the
predictive value of HbA
1c with regard to carotid
atherosclerotic plaque progression and as well as stroke risk in participants.
Acknowledgements
None.References
[1] Gerstein HC, Anand S, Yi QL, et
al. The relationship between dysglycemia and atherosclerosis in South Asian,
Chinese, and European individuals in Canada: a randomly sampled cross-sectional
study. Diabetes Care. 2003;26(1):144-9.
[2] Jørgensen L,
Jenssen T, Joakimsen O, et al. Glycated hemoglobin level is strongly related to
the prevalence of carotid artery plaques with high echogenicity in nondiabetic
individuals: the Tromsø study. Circulation. 2004;110(4):466-70.
[3] Zhao H, Zhao X, Liu X, et al. Association of
carotid atherosclerotic plaque features with acute ischemic stroke: a magnetic
resonance imaging study. Eur J Radiol. 2013;82(9):e465-70.
[4] Kerwin W, Xu
D, Liu F, et al. Magnetic resonance imaging of carotid atherosclerosis: Plaque
analysis. Top Magn Reson Imaging. 2007;18(5):371-78
[5] Saam T,
Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque
composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005;25(1):234-39
[6] Liang K, Sun
Y, Li WJ, et al. Diagnostic efficiency of hemoglobin A1c for newly diagnosed
diabetes and prediabetes in community-based Chinese adults aged 40 years or
older. Diabetes Technol Ther. 2014;16(12):853-7.
[7]
Mukai N, Ninomiya T, Hata J, et al. Association of hemoglobin A1c and glycated
albumin with carotid atherosclerosis in community-dwelling Japanese subjects:
the Hisayama Study. Cardiovasc Diabetol. 2015 ;24(14):84.